Cardinal Health EBIT 2010-2024 | CAH

Cardinal Health annual and quarterly EBIT history from 2010 to 2024. EBIT can be defined as earnings before interest and taxes.
  • Cardinal Health EBIT for the quarter ending September 30, 2024 was $0.568B, a 1875% decline year-over-year.
  • Cardinal Health EBIT for the twelve months ending September 30, 2024 was $1.843B, a 216.12% increase year-over-year.
  • Cardinal Health 2024 annual EBIT was $1.243B, a 65.29% increase from 2023.
  • Cardinal Health 2023 annual EBIT was $0.752B, a 223.89% decline from 2022.
  • Cardinal Health 2022 annual EBIT was $-0.607B, a 228.6% decline from 2021.
Cardinal Health Annual EBIT
(Millions of US $)
2024 $1,243
2023 $752
2022 $-607
2021 $472
2020 $-4,098
2019 $2,060
2018 $126
2017 $2,120
2016 $2,459
2015 $2,161
2014 $1,885
2013 $996
2012 $1,792
2011 $1,514
2010 $1,307
2009 $1,287
Cardinal Health Quarterly EBIT
(Millions of US $)
2024-09-30 $568
2024-06-30 $426
2024-03-31 $367
2023-12-31 $482
2023-09-30 $-32
2023-06-30 $162
2023-03-31 $572
2022-12-31 $-119
2022-09-30 $137
2022-06-30 $25
2022-03-31 $-97
2021-12-31 $-950
2021-09-30 $415
2021-06-30 $162
2021-03-31 $473
2020-12-31 $461
2020-09-30 $-624
2020-06-30 $270
2020-03-31 $562
2019-12-31 $334
2019-09-30 $-5,264
2019-06-30 $308
2019-03-31 $432
2018-12-31 $504
2018-09-30 $816
2018-06-30 $-1,081
2018-03-31 $546
2017-12-31 $399
2017-09-30 $262
2017-06-30 $438
2017-03-31 $605
2016-12-31 $542
2016-09-30 $535
2016-06-30 $620
2016-03-31 $656
2015-12-31 $563
2015-09-30 $620
2015-06-30 $558
2015-03-31 $591
2014-12-31 $546
2014-09-30 $466
2014-06-30 $387
2014-03-31 $508
2013-12-31 $519
2013-09-30 $471
2013-06-30 $-442
2013-03-31 $475
2012-12-31 $506
2012-09-30 $457
2012-06-30 $404
2012-03-31 $527
2011-12-31 $449
2011-09-30 $412
2011-06-30 $359
2011-03-31 $447
2010-12-31 $344
2010-09-30 $364
2010-06-30 $334
2010-03-31 $366
2009-12-31 $367
2009-09-30 $240
2009-06-30 $307
2009-03-31 $381
Sector Industry Market Cap Revenue
Medical Medical & Dental Supplies $28.637B $226.827B
Cardinal Health Inc. is a nation-wide drug distributor and provider of services to pharmacies, healthcare providers and manufacturers. The company has two reporting segments: Pharmaceutical and Medical. The Pharmaceutical segment is the second largest pharmaceutical distributor in the United States and the largest nuclear pharmacy. Its products and services include pharmaceutical distribution, manufacturer and specialty services, and nuclear and pharmacy services. The Medical segment manufactures products such as single-use surgical drapes, gowns and apparel; exam and surgical gloves; and fluid suction and collection systems and offers sterile and non-sterile procedure kits. These products are sold directly or distributed via third-party sources in the U.S., Canada, Europe, South America and the Asia/Pacific.?
Stock Name Country Market Cap PE Ratio
McKesson (MCK) United States $78.151B 21.33
Becton Dickinson (BDX) United States $64.352B 16.92
West Pharmaceutical Services (WST) United States $22.024B 44.99
Labcorp (LH) United States $19.758B 16.38
Cooper (COO) United States $19.726B 28.08
Align Technology (ALGN) United States $16.616B 31.80
Henry Schein (HSIC) United States $9.331B 17.78
Merit Medical Systems (MMSI) United States $6.102B 31.16
DENTSPLY SIRONA (XRAY) United States $3.753B 10.20
CONMED (CNMD) United States $2.216B 18.49
Patterson (PDCO) United States $1.799B 9.49
STAAR Surgical (STAA) United States $1.288B 47.53
Lifevantage (LFVN) United States $0.170B 22.60
Pro-Dex (PDEX) United States $0.147B 29.36